Table 1

Laboratory patterns of different types of VWD

VWF:AgVWF:RCoVWF:RCo/VWF:AgFVIII:CMultimer patternPlatelet countSpecialized testing
Quantitative disorders of VWF        
 Type 1 ↓ ↓ ≥0.6 Normal to ↓ Normal Normal  
 Type 1C ↓ ↓ ≥0.6 Normal to ↓ Normal Normal Increased VWFpp/VWF:Ag ratio 
 Low VWF levels ↓ ↓ ≥0.6 Normal to ↓ Normal Normal  
 Type 3 ↓↓↓ ↓↓↓ ≥0.6 ↓↓↓ Absent Normal  
Qualitative disorders of VWF        
 Type 2A ↓ ↓↓ ≤0.6 Normal to ↓ Loss of HMW-VWF Normal  
 Type 2B ↓ ↓↓ ≤0.6 Normal to ↓ Loss of HMW-VWF ↓↓ LD-RIPA enhanced with patient-derived plasma (VWF) 
 Platelet-type VWD ↓ ↓↓ ≤0.6 Normal Loss of HMW-VWF ↓↓ LD-RIPA enhanced with patient-derived platelets 
 Type 2M ↓ ↓↓ ≤0.6 Normal to ↓ Normal Normal  
 Type 2N Normal to ↓ Normal to ↓ ≥0.6 ↓↓ Normal Normal Decreased VWF:FVIII-binding capacity 
VWF:AgVWF:RCoVWF:RCo/VWF:AgFVIII:CMultimer patternPlatelet countSpecialized testing
Quantitative disorders of VWF        
 Type 1 ↓ ↓ ≥0.6 Normal to ↓ Normal Normal  
 Type 1C ↓ ↓ ≥0.6 Normal to ↓ Normal Normal Increased VWFpp/VWF:Ag ratio 
 Low VWF levels ↓ ↓ ≥0.6 Normal to ↓ Normal Normal  
 Type 3 ↓↓↓ ↓↓↓ ≥0.6 ↓↓↓ Absent Normal  
Qualitative disorders of VWF        
 Type 2A ↓ ↓↓ ≤0.6 Normal to ↓ Loss of HMW-VWF Normal  
 Type 2B ↓ ↓↓ ≤0.6 Normal to ↓ Loss of HMW-VWF ↓↓ LD-RIPA enhanced with patient-derived plasma (VWF) 
 Platelet-type VWD ↓ ↓↓ ≤0.6 Normal Loss of HMW-VWF ↓↓ LD-RIPA enhanced with patient-derived platelets 
 Type 2M ↓ ↓↓ ≤0.6 Normal to ↓ Normal Normal  
 Type 2N Normal to ↓ Normal to ↓ ≥0.6 ↓↓ Normal Normal Decreased VWF:FVIII-binding capacity 

HMW, high molecular weight. ↓, mild decrease; ↓↓, moderate decrease; ↓↓↓, severe decrease.

Close Modal

or Create an Account

Close Modal
Close Modal